These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 629)

  • 1. The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.
    Zivkovic B; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):193-200. PubMed ID: 629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms in the actions of morphine and viminol (R2) on rat striatum.
    Carenzi A; Guidotti A; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1975 Aug; 194(2):311-8. PubMed ID: 239224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?
    el Mestikawy S; Hamon M
    J Neurochem; 1986 Nov; 47(5):1425-33. PubMed ID: 2876053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP content and regulation of tyrosine-3-mono-oxygenase in rat striatum.
    Zivkovic B; Guidotti A; Costa E
    J Cyclic Nucleotide Res; 1976; 2(1):1-10. PubMed ID: 5470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.
    German DC; McMillen BA; Sanghera MK; Saffer SI; Shore PA
    Brain Res Bull; 1981 Feb; 6(2):131-4. PubMed ID: 6110470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Melis MR; Gale K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons.
    Cheronis JC; Erinoff L; Heller A; Hoffmann PC
    Brain Res; 1979 Jun; 169(3):545-60. PubMed ID: 36209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum.
    Guo X; Chen LJ; Buda M; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):289-92. PubMed ID: 1360740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G; Porceddu ML; Spano PF; Gessa GL
    Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term regulation of tyrosine hydroxylase in tonically-active and in tonically-inactive dopamine neurons: effects of haloperidol and protein phosphorylation.
    Iuvone PM
    Life Sci; 1983 Sep; 33(13):1315-24. PubMed ID: 6136885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
    Kogan FJ; Nichols WK; Gibb JW
    Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is forskolin stimulation of rat striatal tyrosine hydroxylase dependent on adenylate cyclase activation?
    Onali P; Olianas MC
    Neurosci Lett; 1992 Oct; 145(2):161-4. PubMed ID: 1361222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol.
    Håkansson K; Pozzi L; Usiello A; Haycock J; Borrelli E; Fisone G
    Eur J Neurosci; 2004 Aug; 20(4):1108-12. PubMed ID: 15305880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.